Gilead Deep Dive
Overview
Based in Foster City, California, Gilead Sciences (GILD) is a leading biotechnology company. The company is involved in discovering, developing, and commercializing innovative therapies. Gilead has the highest market capitalization in the biotechnology industry, amounting to about $175.8 billion. Peers Amgen (AMGN), Celgene (CELG), and Biogen (BIIB) have market capitalizations of about $134.5 billion, $105.3 billion, and $79.3 billion, respectively.
Gilead’s entire HIV product portfolio is based on Viread, which is a brand name of a compound called tenofovir. These drugs accounted for about 42% of the company’s total revenues in 2014. However, in December 2015, Viread will lose its patent protection; provides drugs to eight out of every ten HIV treatment-naïve patients in the United States; HIV portfolio accounts for a substantial 42% of its total revenues
a leading company in manufacturing drugs for HCV (hepatitis C virus)
